Systematic review of the clinical effectiveness and cost-effectiveness of capecitabine (Xeloda®) for locally advanced and/or metastatic breast cancer
2016 ◽
Vol 16
(5)
◽
pp. 549-559
◽
2020 ◽
Vol 36
(12)
◽
pp. 2025-2036
Keyword(s):
Keyword(s):
2009 ◽
Vol 45
(16)
◽
pp. 2749-2758
◽
2008 ◽
Vol 115
(2)
◽
pp. 255-268
◽
Keyword(s):
2019 ◽
Vol 174
(2)
◽
pp. 343-355
◽
Keyword(s):